2023
DOI: 10.1016/j.jbior.2022.100935
|View full text |Cite
|
Sign up to set email alerts
|

Modified lipidomic profile of cancer-associated small extracellular vesicles facilitates tumorigenic behaviours and contributes to disease progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 80 publications
0
2
0
Order By: Relevance
“…EV composition is determined largely by the type and physiological state of the producer cells ( 19 ). EVs show a similar lipid profile as the cell that produced them, including glycosphingolipid, phospholipid, and cholesterol composition ( 20 , 21 , 23 ). Proteins displayed on the surface of nearly all EVs include Alix, tetraspanins (CD9, CD63, and CD81), heat shock protein 70 ( 24 , 25 ), and other proteins that are often associated with specific EV subsets ( 24 , 26 , 27 ).…”
Section: Understanding Ev Tropism Based On Cellular Source and Releva...mentioning
confidence: 99%
See 1 more Smart Citation
“…EV composition is determined largely by the type and physiological state of the producer cells ( 19 ). EVs show a similar lipid profile as the cell that produced them, including glycosphingolipid, phospholipid, and cholesterol composition ( 20 , 21 , 23 ). Proteins displayed on the surface of nearly all EVs include Alix, tetraspanins (CD9, CD63, and CD81), heat shock protein 70 ( 24 , 25 ), and other proteins that are often associated with specific EV subsets ( 24 , 26 , 27 ).…”
Section: Understanding Ev Tropism Based On Cellular Source and Releva...mentioning
confidence: 99%
“…Along with the potential for EVs to deliver therapeutic cargo, several engineering strategies have been reported for luminal loading or surface display of functional proteins or RNA. EVs can be engineered with known or screened cargo and enhance the therapeutic efficacy in disease models (18)(19)(20)(21). Here, we review cell and organ tropism of EVs depending on the source and cellular target, and engineering strategies for EV surface display for targeting delivery.…”
Section: Introductionmentioning
confidence: 99%